Scientists test drug mix in healthy volunteers
NCT ID NCT05469113
Summary
This study tested how a cancer drug (selpercatinib/LOXO-292) affects how the body processes a diabetes medication (repaglinide). It involved 16 healthy adults who took both drugs to measure their levels in the blood and check for safety. The goal was to understand potential drug interactions, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.